Pfizer

Looking at Future Estimates by Analysts for Pfizer
Yahoo/Market Realist
Thu, 01/7/16 - 01:03 pm
Pfizer
Eli Lilly, Pfizer, J&J, AbbVie Join $48M Bet On NYC Cancer Drug Startup
Forbes
Wed, 01/6/16 - 10:26 am
Eli Lilly
Pfizer
JNJ
AbbVie
Petra Pharma
cancer
Pfizer’s Revenues for 4Q15 Are Expected to Grow
Yahoo/Market Realist
Mon, 01/4/16 - 10:43 pm
Pfizer
earnings
Pfizer Inc. Set Up for Big Growth in 2016
Motley Fool
Mon, 01/4/16 - 11:39 am
Pfizer
What's Up Next? Biotech And Pharma Predictions For 2016
Forbes
Fri, 01/1/16 - 01:04 pm
biotech
Martin Shkreli
Valeant Pharmaceuticals
drug pricing
Theranos
Obamacare
Pfizer
CRISPR-Cas9
Cancer Drugs: Strong Growth for Bristol’s Opdivo, Pfizer’s Ibrance
Barron's
Wed, 12/30/15 - 09:01 pm
Bristol-Myers Squibb
Opdivo
Pfizer
Ibrance
Pennywise And Billion-Foolish: Troubling Data For Pfizer's Ian Read
Forbes
Tue, 12/29/15 - 11:39 am
Pfizer
Ian Read
R&D
tax inversions
Bristol-Myers Squibb
Pfizer Inc.'s Best Drug in 2015
Motley Fool
Tue, 12/29/15 - 09:59 am
Pfizer
Ibrance
metastatic breast cancer
Gilead joins Pfizer and Eli Lilly in JAK Race
Bidness, ETC
Sun, 12/27/15 - 10:24 am
Gilead Sciences
JAK inhibitors
Pfizer
Eli Lilly
filgotinib
Galapagos
Xeljanz
baricitinib
The year's top pharma marketing controversies
Medical Marketing and Media
Wed, 12/23/15 - 09:50 pm
FDA
drug pricing
Amarin
social media
PBMs
AstraZeneca
Pfizer
Valeant Pharmaceuticals
drug ads
Afrezza
Pfizer, Merck KGaA launch two more PhIII trials for avelumab
Fierce Biotech
Tue, 12/22/15 - 10:00 pm
Pfizer
Merck KGaA
avelumab
ovarian cancer
anti-PD-L1
Pfizer Inc Mega-Merger to Pit Bayer and Reckitt Against Each Other
Bidness, ETC
Tue, 12/22/15 - 10:48 am
Pfizer
M&A
Bayer
Reckitt Benckiser
consumer health
Ready to step up M&A, Bayer could target big game like Pfizer's OTC unit, Zoetis
Fierce Pharma
Mon, 12/21/15 - 02:59 pm
M&A
Bayer
Pfizer
Zoetis
OTC
animal health
Why Pfizer-Allergan Deal is a Blessing for Healthcare
Bidness, ETC
Tue, 12/15/15 - 09:53 am
Pfizer
Allergan
M&A
Four More Reasons Why Investors Should Nix The Pfizer-Allergan Merger
Forbes
Sun, 12/13/15 - 11:27 am
Pfizer
Allergan
M&A
Pfizer's Viagra market share in China challenged by Guangzhou Baiyunshan's 'golden spear'
Fierce Pharma
Thu, 12/10/15 - 06:30 pm
Pfizer
Viagra
China
erectile dysfunction
Pfizer Announces FDA Acceptance of IBRANCE® (palbociclib) Supplemental New Drug Application with Priority Review in HR+, HER2- Metastatic Breast Cancer
Yahoo
Thu, 12/10/15 - 11:20 am
Pfizer
FDA
Ibrance
priority review
metastatic breast cancer
With Paris spotlight on climate change, here's how Big Pharma stacks up
Fierce Pharma
Wed, 12/9/15 - 11:46 am
climate change
Sanofi
Biogen
Novo Nordisk
JNJ
Pfizer
Merck
Eli Lilly
Shire
Roche
Bristol-Myers Squibb
Pfizer bets up to $1B on BioAtla's approach to immuno-oncology
Fierce Biotech
Wed, 12/9/15 - 09:39 am
Pfizer
BioAtla
immuno-oncology
Pfizer Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for XALKORI® (crizotinib) for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer
Yahoo
Tue, 12/8/15 - 11:24 am
Pfizer
FDA
Xalkori
non-small cell lung cancer

Pages